Skip to main content
TipRanks
Go Ultimate75% OFF

Tarsus Pharmaceuticals (TARS) Ratios

298 Followers

Tarsus Pharmaceuticals Ratios

TARS's free cash flow for Q3 2026 was $-7.21M. For the 2026 fiscal year, TARS's free cash flow was decreased by $-1.21M and operating cash flow was $-6.00M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio3.854.426.9314.6115.33
Quick Ratio3.824.396.8514.6115.33
Cash Ratio1.351.186.094.6414.93
Solvency Ratio-0.30-0.75-1.97-1.77-1.11
Operating Cash Flow Ratio-0.09-1.03-3.18-3.180.33
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ 304.05M$ 204.25M$ 187.63M$ 190.41M$ 163.78M
Leverage Ratios
Debt-to-Assets Ratio0.170.190.110.090.01
Debt-to-Equity Ratio0.270.320.150.100.01
Debt-to-Capital Ratio0.210.240.130.090.01
Long-Term Debt-to-Capital Ratio0.190.240.130.090.00
Financial Leverage Ratio1.641.681.351.181.07
Debt Service Coverage Ratio-6.23-14.30-40.83-28.920.00
Interest Coverage Ratio-7.94-16.19-44.39-30.380.00
Debt to Market Cap0.020.030.050.050.00
Interest Debt Per Share2.452.121.140.900.09
Net Debt to EBITDA1.680.211.480.8612.59
Profitability Margins
Gross Profit Margin93.20%92.99%90.87%96.30%96.36%
EBIT Margin-12.28%-58.87%-759.71%-232.53%-24.15%
EBITDA Margin-11.88%-58.20%-754.69%-231.27%-23.60%
Operating Profit Margin-15.72%-65.90%-820.53%-242.92%-21.32%
Pretax Profit Margin-14.26%-63.16%-778.89%-240.53%-24.15%
Net Profit Margin-14.72%-63.16%-778.89%-240.51%-24.25%
Continuous Operations Profit Margin-14.72%-63.16%-778.89%-240.51%-24.25%
Net Income Per EBT103.20%100.00%100.00%99.99%100.40%
EBT Per EBIT90.69%95.84%94.93%99.02%113.28%
Return on Assets (ROA)-11.81%-30.65%-51.19%-27.25%-7.73%
Return on Equity (ROE)-19.34%-51.46%-68.99%-32.19%-8.29%
Return on Capital Employed (ROCE)-16.64%-40.68%-62.64%-29.52%-7.26%
Return on Invested Capital (ROIC)-16.64%-40.60%-62.53%-29.42%-7.20%
Return on Tangible Assets-11.97%-31.34%-51.94%-27.25%-7.73%
Earnings Yield-1.94%-5.55%-22.84%-17.20%-2.99%
Efficiency Ratios
Receivables Turnover5.183.810.987.21619.86
Payables Turnover1.870.460.090.170.73
Inventory Turnover7.024.900.510.000.00
Fixed Asset Turnover20.7663.845.2116.8531.18
Asset Turnover0.800.490.070.110.32
Working Capital Turnover Ratio1.360.740.080.140.35
Cash Conversion Cycle-72.48-618.95-2989.57-2050.69-501.79
Days of Sales Outstanding70.4495.88370.5950.640.59
Days of Inventory Outstanding52.0174.56711.900.000.00
Days of Payables Outstanding194.93789.394072.052101.33502.38
Operating Cycle122.45170.441082.4850.640.59
Cash Flow Ratios
Operating Cash Flow Per Share-0.30-2.21-4.00-1.990.18
Free Cash Flow Per Share-0.53-2.25-4.19-2.010.15
Dividend Paid and CapEx Coverage Ratio-1.26-52.98-21.35-96.906.40
Capital Expenditure Coverage Ratio-1.26-52.98-21.35-96.906.40
Operating Cash Flow Coverage Ratio-0.13-1.15-3.89-2.431.98
Operating Cash Flow to Sales Ratio-0.03-0.45-6.73-1.900.07
Free Cash Flow Yield-0.65%-4.06%-20.67%-13.72%0.68%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-51.50-18.04-4.38-5.81-33.45
Price-to-Sales (P/S) Ratio7.5811.3834.1013.988.11
Price-to-Book (P/B) Ratio9.969.273.021.872.77
Price-to-Free Cash Flow (P/FCF) Ratio-153.35-24.61-4.84-7.29146.26
Price-to-Operating Cash Flow Ratio-274.78-25.08-5.06-7.36123.39
Price-to-Earnings Growth (PEG) Ratio1.070.54-0.05-0.020.68
Enterprise Value Multiple-62.14-19.34-3.04-5.18-21.77
Enterprise Value3.33B2.06B400.28M309.47M293.03M
EV to EBITDA-62.14-19.34-3.04-5.18-21.77
EV to Sales7.3811.2622.9411.995.14
EV to Free Cash Flow-149.32-24.35-3.25-6.2592.67
EV to Operating Cash Flow-267.55-24.81-3.41-6.3178.18
Tangible Book Value Per Share8.045.756.577.848.11
Shareholders’ Equity Per Share8.225.976.707.848.11
Tax and Other Ratios
Effective Tax Rate-0.030.000.000.00-0.00
Revenue Per Share10.804.870.591.052.77
Net Income Per Share-1.59-3.07-4.62-2.52-0.67
Tax Burden1.031.001.001.001.00
Interest Burden1.161.071.031.031.00
Research & Development to Revenue0.140.292.881.650.73
SG&A to Revenue0.951.300.001.740.45
Stock-Based Compensation to Revenue0.090.151.140.520.15
Income Quality0.190.720.860.79-0.27

Currency in USD